Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
LBT Innovations Limited ( (AU:CC5) ) has shared an announcement.
Clever Culture Systems Ltd announced the impending expiry of its listed options (ASX: CC5OA) on 15 November 2025. Option holders have the choice to exercise, sell, or let their options lapse, with each option convertible into one ordinary share at an exercise price of $0.008. This announcement is crucial for stakeholders as it impacts their potential ownership and investment decisions, with the possibility of issuing 259,775,158 new shares if all options are exercised.
More about LBT Innovations Limited
Clever Culture Systems Ltd, based in Adelaide, South Australia, specializes in intelligent automation solutions for microbiology laboratories. The company has developed the Automated Plate Assessment System (APAS® Independence), an AI-driven technology for automating the imaging, analysis, and interpretation of microbiology culture plates. This technology is the only US FDA-cleared AI solution for automated culture plate reading and is distributed by Thermo Fisher Scientific, Inc to clinical customers in the US and selected European countries.
Average Trading Volume: 2,285,042
Technical Sentiment Signal: Hold
Current Market Cap: A$59.18M
See more insights into CC5 stock on TipRanks’ Stock Analysis page.